Serum Folate in Asthma: Does it Correlate to Severity? A Single Center Experience

Background: Bronchial asthma is the most common chronic childhood illness. It is characterized by airway inflammation and episodic airflow obstruction. Low serum folate has been inconsistently reported as a risk factor for bronchial asthma severity. Other studies reported an increased risk of asthma in children whose mothers received prenatal folic acid supplementation. Aim of the work: To compare serum folate level in asthmatic patients to non-asthmatic healthy controls, and to demonstrate whether folate level correlates to severity &/or frequency of asthma exacerbations and pulmonary function parameters. Methods: Forty-five asthmatic Egyptian children and an equal number of healthy controls were included. Serum folate level was measured in both groups and spirometry was performed for the asthmatic children. Results: Serum folate levels were significantly lower among patients (7.83ng/ml ± 2.47) versus controls (9.84ng/ml ± 3.47), (p value 0.002). Serum folate levels also had an inverse correlation with severity of asthma exacerbations (r = – 0.482), (p = 0.001) and their frequency (r = – 0.418), (p= 0.004). Serum folate levels inversely correlated as well with severity of asthma as a chronic illness (r = – 0.315), (p = 0.035). The cutoff point of serum folate level that was found to increase the severity of asthma exacerbations was calculated at ≤ 8.84ng/ml. Only 7 patients fell below the current normal reference range for serum folate. On the other hand, serum folate level did not significantly correlate with any of the pulmonary function test variables measured. Conclusions: Serum folate levels were lower in asthmatic children when compared to healthy controls, and it negatively correlated with asthma severity and exacerbations, but not to pulmonary function parameters. The cutoff serum folate level for increased severity of asthma exacerbations fell within the normal folate range for children. Further research is recommended to assess any possible beneficial effects for folate supplementation in asthma

Short communication: Supply of methionine during late pregnancy enhances whole-blood innate immune response of Holstein calves partly through changes in mRNA abundance in polymorphonuclear leukocytes

The supply of methionine (Met) in late pregnancy can alter mRNA abundance of genes associated with metabolism and immune response in liver and polymorphonuclear leukocytes (PMN) of the neonatal calf. Whether prenatal supply of Met elicits postnatal effects on systemic inflammation and innate immune response of the calf is not well known. We investigated whether enhancing the maternal supply of Met via feeding ethyl-cellulose rumen-protected Met (RPM) was associated with differences in calf innate immune response mRNA abundance in PMN and systemic indicators of inflammation during the first 50 d of life. Calves (n = 14 per maternal diet) born to cows fed RPM at 0.09% of diet dry matter per day (MET) for the last 28 \ub1 2 d before calving or fed a control diet with no added Met (CON) were used. Blood for biomarker analysis and isolation of PMN for innate immune function assays and mRNA abundance was harvested at birth (before colostrum feeding) and at 7, 21 and 50 d of age. Whole blood was challenged with enteropathogenic bacteria (Escherichia coli 0118:H8) and phagocytosis and oxidative burst of neutrophils and monocytes were quantified via flow cytometry. Although concentration of haptoglobin and activity of myeloperoxidase among calves from both maternal groups increased markedly between 0 and 7 d of age followed by a decrease to baseline at d 21 the responses were lower in MET compared with CON calves. Nitric oxide concentration decreased markedly between 0 and 7 d regardless of maternal group but MET calves tended to have lower overall concentrations during the study. In vitro phagocytosis in stimulated neutrophils increased markedly over time in both CON and MET calves but responses were overall greater in MET calves. Oxidative burst in both neutrophils and monocytes increased over time regardless of maternal treatment. The mRNA abundance of lactate dehydrogenase (LDHA) signal transducer and activator of transcription 3 (STAT3) and S100 calcium binding protein A8 (S100A8) in PMN was overall greater in MET calves. Overall data suggest that increasing the maternal supply of Met during late pregnancy could affect the neonatal calf inflammatory status and innate immune response. Although changes in mRNA abundance could play a role in coordinating the immune response the exact mechanisms merit further stud